WHO Decision Recognizing Obesity as a Disease Treatable with GLP-1 Drugs Is Big Deal, says BU Endocrinologist New guidelines will help reduce stigma around weight management, Ivania Rizo says WHO Decision Recognizing Obesity as a Disease Treatable with GLP-1 Drugs Is Big Deal, says BU Endocrinologist New guidelines will help reduce stigma around weight management, Ivania Rizo says The World Health Organizations new guidelines recognizing obesity as a disease and suggesting that GLP-1 drugs be part of long-term treatment could have wide-ranging benefits, says Ivania Rizo, a Boston University endocrinologist whose research interests center on obesity, diabetes, and metabolic disorders
doi: 10.1016/s0015-0282(02)04679-4
With Real Time Labs it is recommended to take something to bind and pull mycotoxins from the tissues so that it will be excreted in the urine
Glutathione regulates susceptibility to oxidant-induced mitochondrial DNA damage in human lymphocytes
Disease-associated microglia: A universal immune sensor of neurodegeneration
This will allow the resumption of a more normal life-style with a decrease in urinary frequency and nocturia